GSK2110183 is a selective BRAF inhibitor used in cancer therapy, particularly for melanoma with BRAF mutations.
870483-87-7
Dabrafenib Mesylate;GSK-2110183
C17H15BrCl2N4O3
Warning
Pharmaceutical , Specialty Chemicals , Research and Development